SCIENTIFIC PROGRAMME:
Abstracts
Thursday, November 17, 2016
Molecular basis of pathology and therapy in neurological disorders
| 9:15 | Opening Ceremony |
Session I: Neurotoxicity | |
| Chair: | Michal Toborek and Jerzy Lazarewicz |
| 9:30-10:00 | Michal Toborek (Miami, FL, USA) Methamphetamine-induced aberrant neurogenesis in the hippocampus |
| 10:00-10:30 | Leonora Buzanska (Warsaw, Poland) Micro- and macro-scale approach of stem cell based developmental neurotoxicity testing |
| 10:30-11:00 | Coffee break |
| 11:00-11:30 | Malgorzata Kajta and Wladysław Lason (Cracow, Poland) Endocrine disruptors and their neurotoxic effects on developing brain |
| 11:30-12:00 | Jerzy Lazarewicz (Warsaw, Poland)
Triggering role of calcium imbalance in the induction of acute oxidative stress and cytotoxicity in primary cultures of rat cerebellar granule cells challenged with TBBP |
| 12:00-12:15 | Sebastian Hedlund (BIO-RAD) Sneak peak at ZE5, innovating multicolor flow cytometry |
| 12:15-13:45 | Lunch and poster session
|
Session II: Glutaminases in the CNS: norm and pathology | |
| Chair: | Magdalena Zielinska and Monika Szeliga |
| 13:45-14:15 | Jialin Zheng (Nebraska, USA) Glutaminase, HIV-associated neurocognitive disorders and beyond |
| 14:15-14:45 | Antonio Gil Gomez (Sevilla, Spain) Glutaminase, ammonia and Hepatic Encephalopathy: an opportunity for therapy |
| 14:45-15:15 | Inna Gaisler Salomon (Haifa, Israel) Brain glutaminase in psychiatric disease: from mouse models to schizophrenia
|
| 15:15-15:45 | Javier Marquez (Malaga, Spain) Glutamine addiction to brain cancer |
| 15:45-16:00 | Tomasz Budzynski (ROCHE) NGS targeted sequencing with the power of RealTime ready custom qPCR assays |
Friday, November 18, 2016
Stem Cells: Therapeutic Outlook for Central Nervous System Disorders
| 9:15 | Introduction: Krystyna
Domanska-Janik President of Cell Therapy Team of the Central Nervous System Diseases, PAS |
Session I: | |
| Chair: | Wojciech Maksymowicz and Krystyna Domanska-Janik |
| 9:30-10:00 | Yang D. Teng (Boston, USA) Engineered human neural stem cells for treating Spinal Cord Gliomas: A Neurobiology-based approach |
| 10:00-10:30 | Boguslaw Machalinski (Szczecin, Poland) Hematopoietic stem cell-based therapy in neurodegenerative disorders – cellular and humoral mechanisms |
| 10:30-10:45 | Dariusz Rutkowski (BIOKOM) Stem cells - isolation, culture, verification, differentiation and labeling |
| 10:45-11:15 | Coffee break |
Plenary Lecture: | |
| Chair: | Leonora Buzanska |
| 11:15-12:15 | Anders Bjorklund (Lund, Sweden) Stem cell therapy for Parkinson's disease
|
| 12:15-13:45 | Lunch and poster session |
Session II: | |
| Chair: | Boguslaw Machalinski and Yang D. Teng |
| 13:45-14:15 | Juan Gallo (Buenos Aires, Argentina) New strategies of stem cell therapy in retinal disease |
| 14:15-14:45 | Wojciech Maksymowicz (Olsztyn, Poland) Stem cells for ALS: an overview of possible therapeutic approches |
| 14:45-15:15 | Marcin Majka (Cracow, Poland) Stem cells and neurorepair - from bench to clinic and back |
| 15:15-15:45 | Coffee break |
| 15:45-16:15 | Marina A Lynch (Dublin, Ireland) Modulation of microglial activation by CD200R activation in models of neurodegeneration. |
| 16:15-16:45 | Anna Sarnowska (Warsaw, Poland) Pre-transplantation optimization of MSC function for enhancing their regenerative potential |
| 16:45 | Closing ceremony |
POSTER PRESENTATION
- Poster presentation will take place on Thursday and Friday at lunch time.
- Each poster should be no larger than 85 cm x 120 cm. (A0 portrait format).
- The poster boards will be marked with a number in accord a with the scientific program.
- Authors are asked to mount their posters before the morning session, and are required to be present with their posters during the assigned presentation time.
- Please remember to remove your poster at the end of the session.
ORGANIZERS
